A Complex Presentation of Pediatric Neuroleptic Malignant Syndrome Related to Polypharmacy in a 12-Year-Old Male

Journal of Child and Adolescent Psychopharmacology

Volumn 26, Issue 6, 2016, Pages 571-573

  Sharon, Nathaniel ^a   Cullen, Chandra ^a   Martinez, Kara ^a  

^a UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ATYPICAL ANTIPSYCHOTIC AGENT; CEFTRIAXONE; CYPROHEPTADINE; LORAZEPAM; MELATONIN; METHYLPHENIDATE; PAROXETINE; PRAMIPEXOLE; RISPERIDONE; VALPROIC ACID; VANCOMYCIN; NEUROLEPTIC AGENT;

ARM MOVEMENT; BEDTIME DOSAGE; BIPOLAR DISORDER; CASE REPORT; CAUCASIAN; CHILD; COMPUTER ASSISTED TOMOGRAPHY; DIAPHORESIS; ELECTROENCEPHALOGRAM; EMERGENCY HEALTH SERVICE; EMERGENCY WARD; GAIT DISORDER; HUMAN; HYPERSALIVATION; HYPERTHERMIA; INCIDENCE; LETTER; MALE; MENTAL HEALTH; MORNING DOSAGE; MUSCLE RIGIDITY; MYOCLONUS; NEUROLEPTIC MALIGNANT SYNDROME; PEDIATRICS; PHYSICAL EXAMINATION; POLYPHARMACY; SCHOOL CHILD; SEROTONIN SYNDROME; SHIVERING; SLURRED SPEECH;

ANTIPSYCHOTIC AGENTS; CHILD; HUMANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; POLYPHARMACY;

EID: 84983591325     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2014.0125     Document Type: Letter

References (18)

1. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington, DC: American Psychiatric Association; 2013.
2. Boyer EW, Shannon M: The serotonin syndrome. N Engl J Med 352: 1112-1120, 2005.
3. Caley CF: Extrapyramidal reactions and the selective serotonin reuptake inhibitors. Ann Pharmacother 31: 1481-1489, 1997.
4. Caroff SN, Mann SC: Neuroleptic malignant syndrome. Med Clin N Am 77: 185-202, 1993.
5. Croarkin PE, Emslie GJ, Mayes TL: Neuroleptic malignant syndrome associated with atypical antipsychotics in pediatric patients: a review of published cases. J Clin Psychiatry 69: 1157-1165, 2008.
6. Delay J, Pichot P, Lempiere T, Blissalde B, Peigne F: A nonphenothiazine and non-reserpine major neuroleptic, haloperidol, in the treatment of psychoses. Ann Med Psychology (Paris) 118: 145-152, 1960.
7. Friedman JH, Feinberg SS, Feldman RG: A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal. JAMA 254: 2792-2795, 1985.
8. Godinho EM, Thompson AE, Bramble DJ: Neuroleptic withdrawal versus serotonergic syndrome in an 8-year-old child. J Child Adolesc Psychopharmacol 12: 265-270, 2002.
9. Huynh PN, Gathright MM, Holmes KJ, Coffey DB: Worsening psychosis after fever of unknown origin in an adolescent boy with autism. J Child Adolesc Psychopharmacol 23: 224-227, 2013.
10. Kim JM, Lee ST, Song EC, Jung KH, Sinn DI, Chung H, Chu K, Kim M: Neurotoxic syndrome developed after taking sertraline and risperidone. J Clin Neurol 3: 165-167, 2007.
11. Levenson JL: Neuroleptic malignant syndrome. Am J Psychiatry 142: 1137-1145, 1985.
12. Perry PJ: Serotonin syndrome vs neuroleptic malignant syndrome: A contrast of causes, diagnoses and management. Ann Clin Psychiatry 24: 155-162, 2012.
13. Reeves RR, Mack JE, Beddingfield JJ: Neurotoxic syndrome associated risperidone and fluvoxamine. Ann Pharmacother 36: 44043, 2002.
14. Silva RR, Munoz DM, Alpert M, Perlmutter IR, Diaz J: Neuroleptic malignant syndrome in children and adolescents. J Am Acad Child Adolesc Psychiatry 38: 187-194, 1999.
15. Simpson DM, Davis GC: Case report of neuroleptic malignant syndrome associated with withdrawal from amantadine. Am J Psychiatry 1984; 141: 796-797.
16. Steele D, Keltner NL, McGuiness TM: Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome? Perspect Psychiatr Care 47: 58-62, 2011.
17. Stevens DL: Association between selective serotonin reuptake inhibitors, second-generation antipsychotics, and neuroleptic malignant syndrome. Ann Pharmacother 42: 1290-1297, 2008.
18. Wu YF, Kan YS, Yang CH: Neuroleptic malignant syndrome associated with bromocriptine withdrawal in Parkinson's disease-a case report. Gen Hosp Psychiatry 33: 301, 2011.